The use of paclitaxel in the management of early stage breast cancer

The use of paclitaxel in the management of early stage breast cancer

Bibliographic Details
Main Authors:	S Griffin, G Dunn, S Palmer, K Macfarlane, S Brent, A Dyker, S Erhorn, C Humphries, S White, W Horsley, L Ferrie, S Thomas
Format:	Article
Language:	English
Published:	NIHR Journals Library 2009-06-01
Series:	Health Technology Assessment
Online Access:	https://doi.org/10.3310/hta13suppl1/03

Similar Items

Fludarabine phosphate for the first-line treatment of chronic lymphocytic leukaemia
by: S Walker, et al.
Published: (2009-06-01)

Cetuximab plus radiotherapy for the treatment of locally advanced squamous cell carcinoma of the head and neck
by: S Griffin, et al.
Published: (2009-06-01)

Cost-effectiveness of adjuvant paclitaxel and trastuzumab for early-stage node-negative, HER2-positive breast cancer.
by: Ali Hajjar, et al.
Published: (2019-01-01)

Effect of body mass index on pharmacokinetics of paclitaxel in patients with early breast cancer
by: Vikram Gota, et al.
Published: (2021-05-01)

Paclitaxel Promotes Tumor-Infiltrating Macrophages in Breast Cancer
by: Jun Shen MD, et al.
Published: (2020-08-01)

Albumin-bound paclitaxel in the treatment of metastatic breast cancer
by: E V Artamonova
Published: (2017-01-01)

Paclitaxel in breast cancer – drug resistance and strategies to counteract it
by: Alicja Zajdel, et al.
Published: (2019-10-01)

Safety and Efficacy of -Paclitaxel in the Treatment of Patients with Breast Cancer
by: Prakash Vishnu, et al.
Published: (2011-01-01)

Development of polyvinylpyrrolidone/paclitaxel self-assemblies for breast cancer
by: Pallabita Chowdhury, et al.
Published: (2018-07-01)

An Italian cost-effectiveness analysis of paclitaxel albumin (nab-paclitaxel) versus conventional paclitaxel for metastatic breast cancer patients: the COSTANza study
by: Lazzaro C, et al.
Published: (2013-04-01)

Comparative effectiveness of early-line nab-paclitaxel vs. paclitaxel in patients with metastatic breast cancer: a US community-based real-world analysis
by: Mahtani RL, et al.
Published: (2018-02-01)

Cost-effectiveness of bevacizumab plus paclitaxel versus paclitaxel for the first-line treatment of HER2-negative metastatic breast cancer in specialist oncology centers in France
by: Audrey Petitjean, et al.
Published: (2019-02-01)

Case Report: Paclitaxel-Induced Pneumonitis in Early Breast Cancer: A Single Institution Experience and Review
by: Luke Ardolino, et al.
Published: (2021-06-01)

Targeted chemotherapy with nanoparticle albumin-bound paclitaxel (-paclitaxel) in metastatic breast cancer: which benefit for which patients?
by: Raffaella Palumbo, et al.
Published: (2016-05-01)

Safety and Efficacy of nab-Paclitaxel in the Treatment of Patients with Breast Cancer
by: Prakash Vishnu, et al.
Published: (2011-04-01)

The role of nab-paclitaxel in the treatment of patients with metastatic breast cancer
by: M A Frolova
Published: (2016-09-01)

Nab-paclitaxel for the treatment of breast cancer: efficacy, safety, and approval
by: Iwase H, et al.
Published: (2011-07-01)

Delayed Paclitaxel-Trastuzumab-Induced Interstitial Pneumonitis in Breast Cancer
by: Omalkhair Abulkhair, et al.
Published: (2011-04-01)

Genetic Variations Associated with Resistance to Doxorubicin and Paclitaxel in Breast Cancer
by: Ibrahim-zada, Irada
Published: (2012)

Genetic Variations Associated with Resistance to Doxorubicin and Paclitaxel in Breast Cancer
by: Ibrahim-zada, Irada
Published: (2012)

Improved antitumor efficacy of paclitaxel with nano-formulation in breast cancer
by: Ding Shuang, et al.
Published: (2017-06-01)

Prediction of therapeutic response to paclitaxel, docetaxel and ixabepilone in breast cancer
by: Kadra, Gais
Published: (2011)

MENA Confers Resistance to Paclitaxel in Triple-Negative Breast Cancer
by: Han, Sangyoon, et al.
Published: (2018)

Comparative Effectiveness of Platinum plus Paclitaxel versus Platinum plus Cyclophosphamide in Patients with Early-staged Ovarian Cancer
by: Chien-An Chen, et al.
Published: (2014)

Effect of paclitaxel in combined with chemoradiotherapy in inhibiting the cell proliferation of breast cancer in the middle and later stage and the complication prevention measures
by: Wei Huang, et al.
Published: (2016-07-01)

Approaching Neoadjuvant Therapy in the Management of Early-Stage Breast Cancer
by: Hyder T, et al.
Published: (2021-03-01)

Gastrointestinal permeability in ovarian cancer and breast cancer patients treated with paclitaxel and platinum
by: Tichá Alena, et al.
Published: (2007-08-01)

Dose-dense weekly paclitaxel and carboplatin compared with conventional paclitaxel and carboplatin treatment for stage II-IV ovarian cancer patients
by: Zhenhua Du, et al.
Published: (2015-07-01)

Effect of Paclitaxel Loaded Chitosan Nanoparticles and Quantum Dots on Breast Cancer
by: Gülen Melike Demir, et al.
Published: (2017-11-01)

Risk factors for paclitaxel-induced peripheral neuropathy in patients with breast cancer
by: Zohreh Ghoreishi, et al.
Published: (2018-10-01)

Investigation of the Effect of Paclitaxel and Pycnogenol on Mitochondrial Dynamics in Breast Cancer Therapy
by: Suna Sayğılı, et al.
Published: (2017-11-01)

Targeted delivery of albumin bound paclitaxel in the treatment of advanced breast cancer
by: Francesco Di Costanzo, et al.
Published: (2009-07-01)

miR-107 enhances the sensitivity of breast cancer cells to paclitaxel
by: Ma Changpo, et al.
Published: (2019-06-01)

TLR4 is a novel determinant of the response to paclitaxel in breast cancer
by: Rajput, Sandeep
Published: (2014)

The Role Of Breast-Conserving Surgery In The Treatment Of EarlyStage Breast Cancer
by: Fatih Çiftci, et al.
Published: (2020-12-01)

Surgical management for early-stage bilateral breast cancer patients in China.
by: Jia-jian Chen, et al.
Published: (2015-01-01)

High Bak Expression Is Associated with a Favorable Prognosis in Breast Cancer and Sensitizes Breast Cancer Cells to Paclitaxel.
by: Yanwei Luo, et al.
Published: (2015-01-01)

Clusterin Interacts with Paclitaxel and Confer Paclitaxel Resistance in Ovarian Cancer
by: Dong Choon Park, et al.
Published: (2008-09-01)

PARP inhibitors in treatment of early stage breast cancer
by: A. Tutt
Published: (2021-04-01)

A Prospective Study of Adjuvant Radiotherapy Concomitant with Cisplatin Followed by Paclitaxel-Carboplatin in High Risk Early Stage Endometrial Cancer
by: Tarek Kamel, et al.
Published: (2016-12-01)